is.beaulieu
Submits third-party assay reports on material purchased directly. Based in Nantes.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.15%
n=9
Suppliers covered
8
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042796 | Selank | GGPeps | GGPE-2602-G2056 | Janoshik | 2026-Q3 | 98.26 | 7.56 | 97.5 | Buyer-sourced | 0 | FAIL |
| AX-2026-043019 | Semaglutide | KP | KP-2511-J4998 | VendorInvestigate | 2026-Q2 | 99.44 | 7.58 | 94.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041596 | TB-500 | QSC | QSC-2505-C7889 | PeptideMeter | 2025-Q4 | 99.44 | 3.20 | 99.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020603 | Semaglutide | SSA | SSA-2508-Y6894 | PeptideMeter | 2025-Q3 | 99.15 | 4.76 | 99.7 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-020332 | Tirzepatide | MKM | MKM-2411-B2994 | VendorInvestigate | 2025-Q2 | 97.64 | 4.65 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018769 | TB-500 | QSC | QSC-2411-X7470 | Nordanalyt | 2025-Q1 | 99.93 | 5.70 | 101.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019744 | Tirzepatide | HJ | HJ-2502-P3591 | Janoshik | 2025-Q1 | 98.66 | 3.25 | 92.2 | Laboratory-retained | 1 | MARGINAL |
| AX-2024-005508 | Semaglutide | BCH | BCH-2402-K7631 | Nordanalyt | 2024-Q3 | 98.37 | 2.88 | 100.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004509 | L-Glutathione (reduced) | FGP | FGP-2405-E2221 | Janoshik | 2024-Q3 | 99.82 | 6.45 | 101.3 | Supplier-supplied | 1 | MARGINAL |